Donate

ACRF Centre for High-Risk Breast Cancer

Research institute
Princess Alexandra Hospital and Griffith University, QLD
Amount Granted
$2.5 million
Year Granted
2025
Cancer Targeted
Breast Cancer
Research Area
Prevention and Detection

$2.5 million awarded to Princess Alexandra Hospital and Griffith University in Queensland to establish the ACRF Centre for High-Risk Breast Cancer.

ACRF funding will provide a state-of-the-art magnetic resonance spectroscopy (MRS) scanner. This new technology provides a means of assessing the biochemical changes in a woman’s breast tissue, and research will assess results demonstrating that the presence or absence of tumour promoters, to more accurately predict the risk of developing cancer.  

This essentially provides a real-time risk assessment tool which could identify women at imminent risk of developing breast cancer, enabling earlier intervention and potential cure. It will better inform women with these in-transition chemical changes allowing them input into how best to proceed (preventative surgery or medications).

The technology can also provide an alternate to contrast enhanced imaging for determining breast density. For those women unable to tolerate contrast agents or who store contrast agents in their body, MRS can represent an important alternative.

Researchers will conduct longitudinal clinical trials for breast and ovarian cancers, with the goal of making the technology available nationally and internationally.